Watch Ticker

4D Molecular Therapeutics, Inc. Common Stock

Go to 4D Molecular Therapeutics, Inc. Common Stock Website

$5.91

0.67 (12.79%)

Live

Previous Close

$5.24

Day Range

$5.23 - $6.07

Previous Day Range

$5.11 - $6.05

Market Cap

$297.4 million USD

Day Vol.

1.3 million

Previous Day Vol.

3.7 million

Currency

USD

Primary Exchange

Nasdaq

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic a...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

4D Molecular Therapeutics - 4DMT Announces Presentations at 43rd Annual Scientific Meeting of the American Society of Retina Specialists

4D Molecular Therapeutics will present interim results from two clinical trials evaluating 4D-150, a potential treatment for diabetic macular edema and neovascular age-related macular degeneration, at the ASRS Annual Scientific Meeting in July 2025.

Related tickers: FDMT.

Read Full Article

Researchandmarkets.Com - Gene Therapy in Ophthalmology Industry Report 2025-2035: Global Market Poised for Growth as Inherited Retinal Disease Cases Surge Worldwide

The global gene therapy in ophthalmology market is experiencing robust growth, driven by the increasing prevalence of genetic eye diseases, technological advancements, and regulatory support. However, the high cost of treatments and manufacturing challenges remain key concerns.

Related tickers: FDMT.

Read Full Article

Trending Tickers

Please sign in to view